As a new-type foreign trade service provider driven by dual engines of technology transformation and foreign trade services, HiSiaddi has built a "1+2+3+4=1" service system and can supply hyaluronic acid sourced directly from multiple well-known original manufacturers.
As a R&D-oriented foreign trade service provider, HiSiaddi has repeatedly collaborated with factories on technology conversion and conducted multiple rounds of on-site inspections of hyaluronic acid manufacturers, gaining objective and in-depth understanding of different brands. Therefore, we often analyze various hyaluronic acid brands and manufacturers for clients to help them identify suitable products. Below is a brand recommendation case.
Please contact HiSiaddi customer service if you require more comparative analysis of brands and models.
1. Partner Client: LaboSuis High-End Cosmeceutical Laboratory based in Geneva, Switzerland (authentic mid-to-high-end client). It specializes in R&D and production of European salon medical repair serums, post-aesthetic procedure dressings and light luxury medical beauty mesotherapy raw liquids. Its products comply with EP European Pharmacopoeia, Swiss SCCS cosmetic safety regulations and EU REACH chemical specifications, supplying over 200 high-end private medical aesthetics clinics and chain pharmacies across Switzerland, France and Luxembourg. The group purchases 32 tons of medical-grade high-purity sodium hyaluronate annually in three categories: ultra-low molecular weight, medium molecular weight and high molecular weight raw materials. It previously purchased HA from Sweden’s Q-Med and Germany’s BASF, planning domestic substitution for cost reduction in 2025 and conducting its first round of screening for domestic raw materials in China.
2. Client Pain Points: Unfamiliar with domestic leading HA brands, product grades and process differences; independently contacted 5 leading manufacturers for quotation and sampling. Each factory only promotes its own products without slandering competitors, yet avoids objectively explaining the advantages and disadvantages of peer products, leaving the client unable to conduct horizontal parameter comparison and delaying brand selection after sampling over 10 raw material grades.
3. HiSiaddi Positioning: Neutral third-party foreign trade service provider, breaking free from the interests of a single factory to horizontally disassemble the advantages and disadvantages of the 5 major brands, conduct neutral evaluations and screening, and finally confirm 2 major brands + 3 standardized raw material grades for bulk procurement delivery.
All five enterprises are compliant large manufacturers with no malicious slander of peers, yet all focus solely on their own product advantages and avoid mentioning competitors’ strengths and applicable scenarios, leaving the client with severely one-sided information.
1. Bloomage Biotech: Mainly promotes full-series EP-grade medical HA, emphasizing the world’s largest production capacity and complete EU certifications with excellent endotoxin control; omits Haohai’s cross-linking advantages and Focus’s cost advantages for small-molecule products.
2. Haohai Biotech: Prioritizes cross-linked modified HA raw materials, highlighting self-developed cross-linking technology and mature clinical data for medical injection filling raw materials; avoids mentioning Bloomage’s mass production advantages for oligomeric HA and Focus’s cost advantages for bulk daily chemical/food-grade products.
3. Focus Biotech: Specializes in bulk daily chemical and food-grade HA, highlighting large-scale production and cost advantages for standard small-molecule stability; does not introduce Bloomage’s refined production processes for injectable-grade products and Haohai’s technical barriers for high-end cross-linking.
4. Fufeng Biotech: Mainly promotes full-spec food-grade + general cosmetic-grade HA, with advantages of large fermentation capacity and cost-effective raw materials; does not introduce impurity control capabilities of competing high-purity medical grades.
5. Shandong Anhua Biochemical: Mainly promotes small-batch customized daily chemical HA with flexible non-standard molecular weight fine-tuning; avoids mentioning stable mass supply capacity and EU compliance document supporting capabilities of leading large manufacturers.
Client Dilemma: Relying solely on unilateral manufacturer introductions, the client cannot distinguish between injectable medical-grade, salon skincare-grade and general daily chemical-grade product grades. Differences in endotoxin, protein residue and temperature resistance of raw materials with identical molecular weights from different brands remain unclear, leading to frequent turbidity and dissolution agglomeration during laboratory compounding of samples and delayed order confirmation.
· Mainstream Grades: ① UltraHA injectable medium molecular weight (1,200,000Da); ② Hymagic oligomeric ultra-low molecular weight (800Da); ③ High molecular weight 2,300,000Da medical lyophilized powder (EP Pharmacopoeia grade)
· Advantages: Full industrial chain fermentation + four-stage deep depyrogenation, endotoxin ＜0.03EU/mg, all grades registered via EU CosIng and REACH; injectable grades perfectly match the client’s post-aesthetic procedure dressings and mesotherapy raw liquids. Mass production of oligomeric HA is unique domestically with industry-leading transdermal absorption capacity.
· Disadvantages: Premium pricing for high-purity medical grades; cost competitiveness of bulk daily chemical-grade raw materials lags behind Focus and Fufeng.
· Mainstream Grades: ① High-end cross-linked high molecular weight HA (Haimai); ② Dynamic filling medium molecular weight HA (Jiaolan); ③ Non-cross-linked skincare-specific small-molecule HA
· Advantages: Domestically leading cross-linking modification technology; cross-linked HA features strong anti-degradation and long-lasting effects, suitable for deep shaping raw liquids. Medical raw materials have supported domestic Class III medical injection syringes for years with complete clinical data.
· Disadvantages: Limited mass production capacity for linear non-cross-linked ultra-low molecular weight oligomeric HA with long delivery cycles; unit price of conventional non-cross-linked powder higher than Bloomage Biotech.
· Mainstream Grades: Daily chemical small molecular weight (5,000Da~50,000Da), general medium molecular weight (1,000,000Da), food-grade high molecular weight (1,800,000Da)
· Advantages: Large-scale mass production with obvious price advantages for standard grades, high compatibility with general skincare formulas and short delivery cycles.
· Disadvantages: Insufficient refined production lines for high-end injectable grades; impurity indicators (endotoxin, protein residue) of high-purity medical grades fail to meet EP Pharmacopoeia standards, disqualifying them for the client’s injection dressing formulas.
· Mainstream Grades: Full molecular weight food-grade HA, basic cosmetic-grade HA, complete standard oligomeric, medium and high molecular weight grades
· Advantages: Lowest cost for plant-based fermented raw materials with abundant off-the-shelf bulk stock, suitable for mass-produced affordable skincare products.
· Disadvantages: No Class 10,000 sterile refined workshops or EP Pharmacopoeia medical grades; impurity indicators fail to meet Swiss salon medical market access standards.
· Mainstream Grades: Niche customized daily chemical HA, small-batch special molecular weight modified HA
· Advantages: Flexible small-order sampling and convenient fine-tuning of non-standard molecular weights.
· Disadvantages: No EU compliance filing qualifications; limited production capacity unable to support the client’s stable bulk supply of 32 tons annually.
1. Bloomage Hymagic Ultra-Low Molecular Weight 800Da Oligomeric Hyaluronic Acid Applicable to client’s post-aesthetic procedure repair serums (requiring deep transdermal penetration and wound healing promotion) Advantages: EP Pharmacopoeia standard, low endotoxin, exclusive mass production process for oligomers, perfectly matching the transdermal penetration requirements of the client’s serum formulas.
2. Bloomage UltraHA Medium Molecular Weight 1,200,000Da Injectable-Grade HA Applicable to basic salon mesotherapy raw liquids; moderate viscosity, smooth dissolution, no precipitation when compounded with Vitamin C and Niacinamide, complying with Swiss cosmeceutical raw material control standards.
3. Haohai Jiaolan Medium Molecular Weight Cross-Linked Modified HA Applicable to high-end shaping filling raw liquids; leveraging Haohai’s self-developed cross-linking technology, it features anti-degradation performance and low water absorption swelling, matching the client’s light luxury medical beauty filling product line and filling demand for long-lasting high molecular weight raw materials.
1. Sample Control: HiSiaddi coordinates both manufacturers to issue Chinese-English bilingual COAs in accordance with Swiss SCCS and EP Pharmacopoeia standards, and simultaneously sends samples to Swiss SGS third-party laboratories for testing. All three raw materials pass full tests for impurities, endotoxin and formula compatibility stability. No turbidity, agglomeration or storage yellowing occurs during the client’s laboratory compounding.
2. Trial Order Delivery: A 3-ton trial order is issued first (split procurement of three grades), shipped from Shanghai Port directly to Geneva, Switzerland, with no compliance abnormalities during customs clearance and zero production failures after mass production launch.
3. Annual Bulk Order: After 3 months of trial production with excellent end-market feedback on finished products, the client formally signs an annual 32-ton procurement framework, split into 11 tons of oligomeric HA, 13 tons of medium molecular weight linear HA and 8 tons of cross-linked HA, shipped in 6 monthly stable batches.
Compared with original imported European raw materials, comprehensive procurement costs drop by 27%. Domestic raw materials pass Swiss drug filing, and three new products (repair serums, mesotherapy raw liquids and shaping fillers) are successfully launched in Swiss high-end medical beauty channels. The client added procurement demand for new cross-linked hyaluronic acid derivatives the following year.
Secured benchmark long-term orders for high-end European cosmeceuticals, with a 28% export premium for this series of grades. Relying on compliance data from the Swiss client, they subsequently expanded to multiple European cosmeceutical brands in France and Italy.
A horizontal evaluation system for domestic HA five major brands is established, forming a full-link brand selection service covering brand screening → grade benchmarking → third-party testing → compliance support. The business continues to connect raw material procurement projects for mid-to-high-end medical beauty brands across Europe.
Significant brand differentiation exists within China’s hyaluronic acid industry: each leading manufacturer has distinct technical strengths, yet restricted by their own production capacity and sales orientation, they only promote self-owned products and avoid highlighting competitors’ advantages. Mid-to-high-end overseas medical beauty clients are bound by strict European and American pharmacopoeia and local regulatory thresholds for raw material indicators, making it easy to select incorrect grades relying solely on unilateral manufacturer introductions. Leveraging its neutral third-party identity, HiSiaddi comprehensively disassembles the strengths and weaknesses of each brand from all dimensions, precisely narrows down brand and grade options based on the client’s end-formula demands, avoids pitfalls from low-end raw material selection, and achieves a three-way win-win situation: clients reduce costs, manufacturers expand customer bases and service providers increase revenue.
Please contact HiSiaddi customer service if you require more comparative analysis of brands and models.
+86-13120989737 
info@hisiaddi.com 
English
